S7
S7 is an IL-6 receptor antagonist and inhibits the binding between IL-6 and IL-6R. S7 can inhibit angiogenesis and tumor growth[1].
Product Specifications
CAS Number
[853248-13-2]
UNSPSC
12352209
Target
Interleukin Related
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s7.html
Purity
98.25
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(C)C[C@H](N)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O
Molecular Formula
C37H70N10O10
Molecular Weight
815.01
References & Citations
[1]Janelle W. Salameh, et al. Targeted Interleukin-27 Gene Therapy Development for Disrupting Key Malignant Crosstalk between Metastatic Prostate Cancer and Bone.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 4
Isoform
IL-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TRC-B845973-25MG 25 mg
N-(Ethyl-D₅)-N-(2-(2-((2-phenylbutanoyl)oxy)ethoxy)ethyl)ethan-1-amine Oxide-D₅
Ask
View Details 
